Trends in aetiology-based hospitalisation for cirrhosis before and during the COVID-19 pandemic in the United States.

In-hospital mortality in cirrhosis was higher in the COVID-19 era than in the pre-COVID-19 era. ALD is the leading aetiology-specific cause of in-hospital mortality in cirrhosis with an independent detrimental impact of the COVID-19 infection.